Pediatric Vaccines - Global Market Outlook (2015-2022)

Pediatric Vaccines - Global Market Outlook (2015-2022)

  • Published: March 2016
  • ID: SMRC15608

According to Stratistics MRC, the Global Pediatric Vaccines market is estimated at $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Rising government and non-government financial support for development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines, little accessibility to remote areas and strict regulation for approval of vaccines are some of the factors hampering the global pediatric vaccine market.

Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.

Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.

Diseases type Covered:
• Cancer and allergy
• Infectious disease
o Pneumococcal disease
o Influenza
o Diphtheria
o Rotavirus
o Tetanus
o Haemophilus Influenzae type b (Hib)
o Meningococcal
o Hepatitis A
o Hepatitis B
o Rubella
o Mumps
o Measles
o Pertussis
o Varicella (chickenpox)
o Polio

Products Covered:
• Anti-infective drugs
• Pediatric hormones
• Allergy & respiratory drugs
• CNS drugs

Vaccines type Covered:
• Synthetic vaccines
• Conjugate vaccines
• Live attenuated vaccines
• Dendritic cells vaccines
• Toxoid vaccines
• Recombinant vector vaccines 
• Subunit vaccines
• Inactivated vaccines

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil      
o Argentina       
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary
   
2 Preface 

 2.1 Abstract
 2.2 Stake Holders
 2.3 Research Scope
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
   
3 Market Trend Analysis
 3.1 Introduction
 3.2 Drivers 
 3.3 Restraints
 3.4 Opportunities
 3.5 Threats 
 3.6 Product Analysis 
 3.7 Emerging Markets
   
4 Porters Five Force Analysis
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry
   
5 Global Pediatric Vaccines Market, By Diseases type
 5.1 Introduction 
 5.2 Cancer and allergy
 5.3 Infectious disease
  5.3.1 Pneumococcal disease
  5.3.2 Influenza
  5.3.3 Diphtheria
  5.3.4 Rotavirus
  5.3.5 Tetanus
  5.3.6 Haemophilus Influenzae type b (Hib)
  5.3.7 Meningococcal
  5.3.8 Hepatitis A
  5.3.9 Hepatitis B
  5.3.10 Rubella
  5.3.11 Mumps
  5.3.12 Measles
  5.3.13 Pertussis
  5.3.14 Varicella (chickenpox)
  5.3.15 Polio
   
6 Global Pediatric Vaccines Market, By Product
 6.1 Introduction 
 6.2 Anti-infective drugs
 6.3 Pediatric hormones
 6.4 Allergy & respiratory drugs
 6.5 CNS drugs
   
7 Global Pediatric Vaccines Market, By Vaccines type
 7.1 Introduction 
 7.2 Synthetic vaccines
 7.3 Conjugate vaccines
 7.4 Live attenuated vaccines
 7.5 Dendritic cells vaccines
 7.6 Toxoid vaccines
 7.7 Recombinant vector vaccines
 7.8 Subunit vaccines
 7.9 Inactivated vaccines
   
8 Global Pediatric Vaccines Market, By Geography
 8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
 8.2 Europe 
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.6 Rest of Europe
 8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
 8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt
   
9 Key Developments
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers
 9.3 New Product Launch
 9.4 Expansions
 9.5 Other Key Strategies
   
10 Company Profiling
 10.1 Johnson and Johnson
 10.2 Abbott Laboratories
 10.3 Baxter International
 10.4 Eli Lilly and Company
 10.5 Sanofi S.A 
 10.6 Novo Nordisk A/S 
 10.7 Bharat Biotech International Limited
 10.8 Actelion Pharmaceuticals Ltd
 10.9 Genentech, Inc. 
 10.10 Shire Pharmaceuticals Group Plc
 10.11 Merck & Co. Inc
 10.12 Bristol-Myers Squibb Company
 10.13 Amgen Inc.
 10.14 Novartis AG.
 10.15 Boehringer Ingelheim GmbH


List of Tables 
1 Global Pediatric Vaccines Market Outlook, By Region (2013-2022) ($MN)
2 Global Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
3 Global Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
4 Global Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
5 Global Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
6 Global Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
7 Global Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
8 Global Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
9 Global Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
10 Global Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
11 Global Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
12 Global Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
13 Global Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
14 Global Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
15 Global Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
16 Global Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
17 Global Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
18 Global Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
19 Global Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
20 Global Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
21 Global Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
22 Global Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
23 Global Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
24 Global Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
25 Global Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
26 Global Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
27 Global Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
28 Global Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
29 Global Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
30 Global Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
31 Global Pediatric Vaccines Market Outlook, By Recombinant vector vaccines  (2013-2022) ($MN)
32 Global Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
33 Global Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
34 North America Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
35 North America Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
36 North America Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
37 North America Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
38 North America Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
39 North America Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
40 North America Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
41 North America Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
42 North America Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
43 North America Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
44 North America Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
45 North America Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
46 North America Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
47 North America Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
48 North America Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
49 North America Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
50 North America Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
51 North America Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
52 North America Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
53 North America Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
54 North America Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
55 North America Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
56 North America Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
57 North America Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
58 North America Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
59 North America Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
60 North America Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
61 North America Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
62 North America Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
63 North America Pediatric Vaccines Market Outlook, By Recombinant vector vaccines  (2013-2022) ($MN)
64 North America Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
65 North America Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
66 Europe Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
67 Europe Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
68 Europe Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
69 Europe Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
70 Europe Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
71 Europe Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
72 Europe Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
73 Europe Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
74 Europe Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
75 Europe Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
76 Europe Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
77 Europe Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
78 Europe Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
79 Europe Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
80 Europe Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
81 Europe Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
82 Europe Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
83 Europe Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
84 Europe Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
85 Europe Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
86 Europe Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
87 Europe Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
88 Europe Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
89 Europe Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
90 Europe Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
91 Europe Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
92 Europe Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
93 Europe Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
94 Europe Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
95 Europe Pediatric Vaccines Market Outlook, By Recombinant vector vaccines  (2013-2022) ($MN)
96 Europe Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
97 Europe Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
98 Asia Pacific Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
99 Asia Pacific Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
100 Asia Pacific Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
101 Asia Pacific Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
102 Asia Pacific Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
103 Asia Pacific Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
104 Asia Pacific Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
105 Asia Pacific Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
106 Asia Pacific Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
107 Asia Pacific Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
108 Asia Pacific Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
109 Asia Pacific Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
110 Asia Pacific Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
111 Asia Pacific Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
112 Asia Pacific Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
113 Asia Pacific Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
114 Asia Pacific Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
115 Asia Pacific Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
116 Asia Pacific Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
117 Asia Pacific Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
118 Asia Pacific Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
119 Asia Pacific Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
120 Asia Pacific Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
121 Asia Pacific Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
122 Asia Pacific Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
123 Asia Pacific Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
124 Asia Pacific Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
125 Asia Pacific Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
126 Asia Pacific Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
127 Asia Pacific Pediatric Vaccines Market Outlook, By Recombinant vector vaccines  (2013-2022) ($MN)
128 Asia Pacific Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
129 Asia Pacific Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
130 Rest of the World Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
131 Rest of the World Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
132 Rest of the World Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
133 Rest of the World Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
134 Rest of the World Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
135 Rest of the World Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
136 Rest of the World Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
137 Rest of the World Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
138 Rest of the World Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
139 Rest of the World Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
140 Rest of the World Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
141 Rest of the World Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
142 Rest of the World Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
143 Rest of the World Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
144 Rest of the World Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
145 Rest of the World Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
146 Rest of the World Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
147 Rest of the World Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
148 Rest of the World Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
149 Rest of the World Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
150 Rest of the World Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
151 Rest of the World Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
152 Rest of the World Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
153 Rest of the World Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
154 Rest of the World Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
155 Rest of the World Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
156 Rest of the World Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
157 Rest of the World Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
158 Rest of the World Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
159 Rest of the World Pediatric Vaccines Market Outlook, By Recombinant vector vaccines  (2013-2022) ($MN)
160 Rest of the World Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
161 Rest of the World Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials